Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBBGI Global Infrastructure Regulatory News (BBGI)

  • There is currently no data for BBGI

Dividend Declaration

16 May 2013 09:22

RNS Number : 8716E
Bilfinger Berger Gbl Infrstre SICAV
16 May 2013
 



16 May 2013

 

Bilfinger Berger Global Infrastructure SICAV S.A.

(the "Company"/"BBGI")

 

 

Final Dividend

 

On 1 May 2013, the Company reported that a final dividend with scrip alternative for the year ended 31 December 2012 had been approved by shareholders at the Company's AGM on 30 April 2013. It also advised that, in accordance with the Company's Articles, a scrip alternative would not be available if the Scrip Price stood in excess of 5% of the net asset value per share, and that in this event, a cash dividend only would be paid.

 

The Company's most recent investment basis net asset value is 103.5pence per share, as at 31 December 2012. Using the calculation method announced on 1 May 2013, the scrip price stands at 115.89 pence per share. This means the scrip price is 12% higher than the investment basis net asset value, in excess of the 5% per the calculation method. Accordingly, the scrip alternative will not be offered and a cash dividend only will be paid on the timetable announced on 1 May 2013:

 

Dividend per share: 2.75 pence

Ex-Dividend date: 8 May 2013

Dividend Record date: 10 May 2013

Payment date: 31 May 2013

 

 

For further information, please contact:

 

Bilfinger Berger Global Infrastructure SICAV S.A. +352 26 34 79-1

Frank Schramm

Duncan Ball

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DIVGIGDUCBBBGXL
Date   Source Headline
18th Dec 20207:00 amRNSCompletion of Acquisition
14th Dec 20202:30 pmEQSHardman & Co Research: BBGI Global Infrastructure (Initiation of coverage): Delivering NAV and dividend growth since 2011
1st Dec 20202:45 pmRNSDematerialisation of Ordinary Shares
30th Nov 20206:10 pmRNSResult of Meeting
30th Nov 20205:25 pmRNSTotal Voting Rights
27th Nov 20206:11 pmRNSHolding(s) in Company
27th Nov 20201:59 pmRNSIntention to conduct audit tender
24th Nov 20205:13 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Equity Issue
17th Nov 20207:05 amRNSProposed Placing
17th Nov 20207:00 amRNSAcquisition
3rd Nov 20203:29 pmRNSHolding(s) in Company
30th Oct 20204:39 pmRNSTotal Voting Rights
29th Oct 20205:31 pmRNSNotice of EGM
29th Oct 20201:39 pmRNSHolding(s) in Company
27th Oct 20203:14 pmRNSChange of Name
27th Oct 202012:40 pmRNSResult of Meeting
23rd Oct 20205:18 pmRNSDirector/PDMR Shareholding
23rd Oct 20204:48 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAdditional Listing
8th Oct 20203:59 pmRNSHolding(s) in Company
8th Oct 202012:56 pmRNSHolding(s) in Company
6th Oct 20208:50 amRNSHolding(s) in Company
28th Sep 20202:51 pmRNSHolding(s) in Company
24th Sep 20205:40 pmRNSNotice of EGM
24th Sep 20202:46 pmRNSHolding(s) in Company
23rd Sep 20205:16 pmRNSHolding(s) in Company
21st Sep 20204:33 pmRNSScrip Dividend Circular
16th Sep 20209:49 amRNSHolding(s) in Company
15th Sep 20209:38 amRNSHalf-year Report
9th Sep 20202:06 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDividend Declaration
28th Aug 20207:00 amRNSHalf-year Report
19th Aug 20206:02 pmRNSDirector Declaration
19th Aug 20207:00 amRNSAcquisition
13th Aug 20207:10 amRNSDate of Interim Results and Analysts Presentation
7th Jul 20203:04 pmRNSHolding(s) in Company
29th Jun 20204:38 pmRNSCommittee changes
29th Jun 20207:00 amRNSDirectorate Change
26th Jun 202010:40 amRNSHolding(s) in Company
26th Jun 202010:30 amRNSHolding(s) in Company
26th Jun 202010:29 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSTotal Voting Rights
20th May 20207:00 amRNSDirector/PDMR Shareholding
14th May 20201:20 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSAdditional Listing
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 20202:42 pmRNSResults of Annual General Meeting
14th Apr 202010:19 amRNSAnnual Financial Report
1st Apr 20207:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.